REDUCTION OF BIOGENIC-AMINE LEVELS IN THE RETT SYNDROME
REDUCTION OF BIOGENIC-AMINE LEVELS IN THE RETT SYNDROME
复制标题
DOI:
10.1056/nejm198510103131504
复制
发表时间:
1985-01-01
影响因子:
158.5
通讯作者:
RICCARDI, VM
中科院分区:
文献类型:
--
作者:
ZOGHBI, HY;PERCY, AK;RICCARDI, VM
The Rett syndrome is a progressive disorder in female patients that is characterized by autistic behavior, demetia, ataxia, loss of purposeful use of the hands,, and seizures. The results of laboratory investigations are usually normal, with the exception of electroencephalography. In an attempt to understand the pathogenesis of this syndrome, we assayed biogenic amine metabolites in the cerebrospinal fluid of six patients, 2 to 15 years of age. 3-Methoxy-4-hydroxyphenylethylene glycol (MHPG, a metabolite of norepinephrine), homovanillic acid (a metabolite of dopamine), and 5-hydroxyindoleacetic acid (5-HIAA, a metabolite of serotonin) were quantitated by a method involving gas chromatography and mass spectrometry. Levels of MHPG andhomovanillic acid were significantly reduced in all the patients as compared with those in controls of similar age (P = 0.01 and 0.008, respectively). The reduction in the level of 5-HIAA was not significantly differet from that in the controls (P = 0.15). These findings suggest an underlying disorder of biogenic amines in the Rett syndrome and may provide new insight into its pathogenesis.